In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Supplement GMPs

This article was originally published in The Tan Sheet

Executive Summary

Supplement GMPs: FDA extending comment period for Feb. 6 advance notice of proposed rulemaking on Good Manufacturing Practice regulations for supplements to June 6 from the original May 7 deadline ("The Tan Sheet" Feb. 10, p. 2). FDA says in the May 6 Federal Register announcement of the extension that it is allowing more time for comments due to several requests. The Nonprescription Drug Manufacturers Association, Council for Responsible Nutrition, Nutritional Health Alliance and private labeler Perrigo requested extensions...
Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS087037

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel